home / stock / crxtw / crxtw short
Short Information | Clarus Therapeutics Holdings Inc. Warrant 9/9/2026 (NASDAQ:CRXTW)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 131,608 |
Total Actual Volume | 1,609,346 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 6,580 |
Average Short Percentage | 8.53% |
Is there a CRXTW Short Squeeze or Breakout about to happen?
See the CRXTW Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
08-30-2022 | $0.019 | $0.06 | $0.0211 | $0.0112 | 435,910 | 3,645 | 0.84% |
08-29-2022 | $0.0225 | $0.06 | $0.0259 | $0.0186 | 292,886 | 35,778 | 12.22% |
08-26-2022 | $0.0332 | $0.06 | $0.0401 | $0.0281 | 121,875 | 20,000 | 16.41% |
08-24-2022 | $0.02 | $0.06 | $0.03 | $0.02 | 94,487 | 18,734 | 19.83% |
08-23-2022 | $0.028 | $0.06 | $0.03 | $0.025 | 124,155 | 9,325 | 7.51% |
08-22-2022 | $0.038 | $0.06 | $0.0399 | $0.0289 | 287,008 | 24,730 | 8.62% |
08-18-2022 | $0.0738 | $0.06 | $0.0738 | $0.06 | 29,828 | 3,200 | 10.73% |
08-17-2022 | $0.0598 | $0.06 | $0.0769 | $0.0465 | 59,078 | 2,244 | 3.8% |
08-16-2022 | $0.061 | $0.06 | $0.069 | $0.0553 | 4,699 | 385 | 8.19% |
08-15-2022 | $0.0597 | $0.06 | $0.08 | $0.0595 | 18,445 | 3,960 | 21.47% |
08-11-2022 | $0.0698 | $0.06 | $0.079 | $0.0651 | 8,195 | 10 | 0.12% |
08-10-2022 | $0.065201 | $0.06 | $0.0724 | $0.0651 | 14,529 | 43 | 0.3% |
08-09-2022 | $0.0666 | $0.06 | $0.0666 | $0.0666 | 3,947 | 3 | 0.08% |
08-08-2022 | $0.059 | $0.06 | $0.0701 | $0.059 | 6,414 | 701 | 10.93% |
08-03-2022 | $0.0597 | $0.06 | $0.0597 | $0.055 | 22,730 | 200 | 0.88% |
08-02-2022 | $0.051 | $0.06 | $0.0597 | $0.051 | 3,801 | 300 | 7.89% |
08-01-2022 | $0.060201 | $0.06 | $0.0602 | $0.055 | 20,985 | 6,500 | 30.97% |
07-26-2022 | $0.06 | $0.06 | $0.0601 | $0.058 | 22,876 | 250 | 1.09% |
07-25-2022 | $0.0597 | $0.06 | $0.06 | $0.0552 | 19,184 | 100 | 0.52% |
07-19-2022 | $0.0648 | $0.0602 | $0.0648 | $0.06 | 18,314 | 1,500 | 8.19% |
News, Short Squeeze, Breakout and More Instantly...
Clarus Therapeutics Holdings Inc. Warrant 9/9/2026 Company Name:
CRXTW Stock Symbol:
NASDAQ Market:
NORTHBROOK, Ill., Sept. 05, 2022 (GLOBE NEWSWIRE) -- Clarus Therapeutics Holdings, Inc. (Clarus) (OTC: CRXT), a pharmaceutical company dedicated to providing solutions to unmet medical needs by advancing androgen therapies, announced today that it, together with its wholly-owned subsidiary ...
Second quarter 2022 net revenue increased 46% year-over-year to $4.1 million Second quarter 2022 total prescription growth for JATENZO® increased 23% sequentially and increased 72% year-over-year Immediate reduction in workforce by approximately 40% of total headcou...
JATENZO is the first and only FDA-approved oral softgel for testosterone replacement therapy in adult males who have deficient testosterone due to certain medical conditions NORTHBROOK, Ill., July 28, 2022 (GLOBE NEWSWIRE) -- Clarus Therapeutics Holdings, Inc. (Clarus) (Nasdaq:CRXT)...